{"id":4562,"date":"2025-04-24T15:31:26","date_gmt":"2025-04-24T12:31:26","guid":{"rendered":"https:\/\/docdrmuratkaya.com.tr\/?p=4562"},"modified":"2026-04-29T14:12:18","modified_gmt":"2026-04-29T11:12:18","slug":"yumusak-doku-tumoru","status":"publish","type":"post","link":"https:\/\/docdrmuratkaya.com.tr\/en\/yumusak-doku-tumoru\/","title":{"rendered":"Yumu\u015fak Doku T\u00fcm\u00f6r\u00fc"},"content":{"rendered":"<p data-block-id=\"f96e34b1-7cb5-44b0-a9a1-46dba0eacb01\" data-pm-slice=\"1 1 []\">Kas, ya\u011f, sinir, damar gibi dokularda olu\u015fan anormal h\u00fccre b\u00fcy\u00fcmesidir. <strong>Yumu\u015fak doku t\u00fcm\u00f6r\u00fc<\/strong>, genellikle iyi huyludur. Bazen k\u00f6t\u00fc huylu olabilir. V\u00fccudun her yerinde g\u00f6r\u00fclebilir. \u015ei\u015flik, a\u011fr\u0131 ya da hareket k\u0131s\u0131tl\u0131l\u0131\u011f\u0131 yapabilir. Tan\u0131 i\u00e7in g\u00f6r\u00fcnt\u00fcleme ve biyopsi gerekir. Erken te\u015fhis \u00f6nemlidir. Tedavi genellikle cerrahi ile yap\u0131l\u0131r. Gerekirse ek tedaviler uygulan\u0131r.<\/p>\n<h2 data-block-id=\"1e321f57-ce33-4ed6-8cf7-c6398b85f8de\">Yumu\u015fak Doku T\u00fcm\u00f6r\u00fc Belirtileri Nelerdir?<\/h2>\n<p><img decoding=\"async\" class=\"wp-image-5448 alignleft\" src=\"https:\/\/docdrmuratkaya.com.tr\/wp-content\/uploads\/2025\/04\/yumusak-doku-tumoru-1-1.jpg\" alt=\"Yumu\u015fak Doku T\u00fcm\u00f6r\u00fc\" width=\"380\" height=\"199\" title=\"\" srcset=\"https:\/\/docdrmuratkaya.com.tr\/wp-content\/uploads\/2025\/04\/yumusak-doku-tumoru-1-1.jpg 1200w, https:\/\/docdrmuratkaya.com.tr\/wp-content\/uploads\/2025\/04\/yumusak-doku-tumoru-1-1-18x9.jpg 18w\" sizes=\"(max-width: 380px) 100vw, 380px\" \/><\/p>\n<p>V\u00fccutta elle hissedilen kitle en s\u0131k kar\u015f\u0131la\u015f\u0131lan belirtidir. Genellikle a\u011fr\u0131s\u0131z bir \u015fi\u015flik \u015feklindedir. Bu kitle zamanla b\u00fcy\u00fcyebilir ve sertlik hissi yaratabilir. Kitle, kol, bacak, s\u0131rt gibi kas dokular\u0131n\u0131n yo\u011fun oldu\u011fu b\u00f6lgelerde daha s\u0131k fark edilir.<\/p>\n<p data-block-id=\"27e89e6c-0b17-4d3b-ba22-74ed495556d2\">Bu nedenle bir kitle fark edildi\u011finde zamanla b\u00fcy\u00fcy\u00fcp b\u00fcy\u00fcmedi\u011fi mutlaka takip edilmelidir. Baz\u0131<strong> yumu\u015fak doku t\u00fcm\u00f6r\u00fc<\/strong> vakalar\u0131 sinirlere veya kaslara bask\u0131 yaparak a\u011fr\u0131ya yol a\u00e7abilir. \u00d6zellikle hareket s\u0131ras\u0131nda artan a\u011fr\u0131 veya bask\u0131 hissi, \u00e7evre dokular\u0131n etkilenmi\u015f olabilece\u011fini g\u00f6sterir.<\/p>\n<p data-block-id=\"27e89e6c-0b17-4d3b-ba22-74ed495556d2\">Ancak t\u00fcm t\u00fcm\u00f6rler a\u011fr\u0131ya neden olmaz. T\u00fcm\u00f6r eklem yak\u0131n\u0131nda veya kaslar\u0131n i\u00e7inde yer al\u0131yorsa, b\u00f6lgenin hareketini k\u0131s\u0131tlayabilir. Bu durum genellikle b\u00fcy\u00fck boyutlara ula\u015fan ya da \u00f6nemli yap\u0131lar\u0131 etkileyen t\u00fcm\u00f6rlerde g\u00f6r\u00fcl\u00fcr. Baz\u0131 durumlarda t\u00fcm\u00f6r\u00fcn \u00fczerinde bulunan ciltte renk de\u011fi\u015fikli\u011fi, morarma ya da incelme gibi belirtiler g\u00f6zlenebilir.<\/p>\n<p data-block-id=\"27e89e6c-0b17-4d3b-ba22-74ed495556d2\">Bu t\u00fcr de\u011fi\u015fiklikler genellikle t\u00fcm\u00f6r\u00fcn y\u00fczeye yak\u0131n yerle\u015fti\u011fi durumlarda ortaya \u00e7\u0131kar. T\u00fcm\u00f6r, bir sinire bask\u0131 yap\u0131yorsa uyu\u015fma, kar\u0131ncalanma ya da elektrik \u00e7arpmas\u0131 benzeri hisler olu\u015fabilir. Bu belirtiler genellikle kol veya bacak gibi uzuvlarda hissedilir.<\/p>\n<p data-block-id=\"457f5146-e96b-44c6-95d7-3d27be618626\" data-pm-slice=\"1 1 []\">K\u00f6t\u00fc huylu t\u00fcm\u00f6rler nadiren genel sa\u011fl\u0131k durumunu da etkileyebilir. Bu durumda hastada a\u00e7\u0131klanamayan kilo kayb\u0131, halsizlik ve i\u015ftahs\u0131zl\u0131k gibi genel belirtiler g\u00f6r\u00fclebilir. T\u00fcm\u00f6r, damarlar\u0131n \u00fczerine bask\u0131 yaparsa \u015fi\u015flik, \u00f6dem veya kan dola\u015f\u0131m\u0131nda bozulma olabilir. Bu durum \u00f6zellikle bacaklarda \u015fi\u015flik \u015feklinde kendini g\u00f6sterir. Bu belirtiler, genellikle<strong> yumu\u015fak doku t\u00fcm\u00f6r\u00fc<\/strong> varl\u0131\u011f\u0131n\u0131n g\u00f6stergesi olabilir.<\/p>\n<h3 data-block-id=\"fe3c3368-b27b-4423-b25f-2a53a4d338c5\">Yumu\u015fak Doku T\u00fcm\u00f6r\u00fc Neden Olur?<\/h3>\n<p data-block-id=\"b06214c3-5c69-4d46-9c86-6e4c91754418\">Baz\u0131 genetik sendromlar t\u00fcm\u00f6rlerin olu\u015fumuna zemin haz\u0131rlar. \u00d6rne\u011fin Li-Fraumeni sendromu, neurofibromatosis (NF1) ve Gardner sendromu gibi kal\u0131tsal hastal\u0131klar, t\u00fcm\u00f6r geli\u015fme riskini art\u0131r\u0131r. Bu sendromlara sahip bireylerde t\u00fcm\u00f6rler \u00e7ocukluk \u00e7a\u011f\u0131nda dahi ortaya \u00e7\u0131kabilir. Ge\u00e7mi\u015fte al\u0131nan radyoterapi tedavisi veya y\u00fcksek dozda radyasyona maruz kalmak, \u00f6zellikle sarkom gibi k\u00f6t\u00fc huylu t\u00fcm\u00f6rlerin geli\u015fme riskini art\u0131r\u0131r. Bu t\u00fcr t\u00fcm\u00f6rler genellikle y\u0131llar sonra ortaya \u00e7\u0131kar.<\/p>\n<p data-block-id=\"b06214c3-5c69-4d46-9c86-6e4c91754418\">Uzun s\u00fcreli pestisit, herbisit, vinil klor\u00fcr veya end\u00fcstriyel kimyasallar gibi zararl\u0131 maddelere maruz kalmak, h\u00fccrelerde mutasyona yol a\u00e7arak t\u00fcm\u00f6r olu\u015fumuna neden olur. Bu durum \u00f6zellikle belirli meslek gruplar\u0131nda daha yayg\u0131n g\u00f6r\u00fclebilir.<\/p>\n<p data-block-id=\"b06214c3-5c69-4d46-9c86-6e4c91754418\">Ba\u011f\u0131\u015f\u0131kl\u0131k sistemi zay\u0131f olan bireylerde, v\u00fccut h\u00fccreler \u00fczerindeki kontrol\u00fcn\u00fc kaybedebilir. Anormal h\u00fccre \u00e7o\u011falmas\u0131 ba\u015flayabilir. \u00d6zellikle organ nakli sonras\u0131 ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131 bask\u0131layan ila\u00e7 kullanan ki\u015filerde bu risk artar. Tekrarlayan travmalar ya da uzun s\u00fcreli doku hasarlar\u0131, b\u00f6lgedeki h\u00fccrelerin yap\u0131s\u0131nda bozulmalara yol a\u00e7ar. Bu durum da zamanla t\u00fcm\u00f6r olu\u015fumunu tetikleyebilir.<\/p>\n<p data-block-id=\"b17ba009-f0eb-4bcd-84b3-f773d2dbdf99\" data-pm-slice=\"1 1 []\"><strong>Yumu\u015fak doku t\u00fcm\u00f6r\u00fc<\/strong> olu\u015fum riskini art\u0131ran fakt\u00f6rler aras\u0131nda baz\u0131 vir\u00fcsler ve hormon dengesizlikleri bulunur. Ancak bu ili\u015fki kesin de\u011fildir ve destekleyici veri s\u0131n\u0131rl\u0131d\u0131r. Nadir de olsa baz\u0131 vir\u00fcsler, \u00f6zellikle ba\u011f\u0131\u015f\u0131kl\u0131k sistemi zay\u0131flam\u0131\u015f ki\u015filerde t\u00fcm\u00f6r geli\u015fimine neden olabilir. \u00d6rne\u011fin HHV-8 (Human Herpesvirus 8), Kaposi sarkomu ad\u0131 verilen bir t\u00fcr ile ili\u015fkilidir. Baz\u0131 hormonlar veya b\u00fcy\u00fcme fakt\u00f6rlerinin anormal \u00fcretimi ya da etkisi, h\u00fccre b\u00fcy\u00fcmesini ve \u00e7o\u011falmas\u0131n\u0131 kontrols\u00fcz hale getirir. Bu durum, baz\u0131 t\u00fcm\u00f6rlerin geli\u015fimine katk\u0131da bulunabilir.<\/p>\n<h3 data-block-id=\"1e321f57-ce33-4ed6-8cf7-c6398b85f8de\" data-pm-slice=\"1 1 []\">Yumu\u015fak Doku T\u00fcm\u00f6r\u00fc Kimlerde G\u00f6r\u00fcl\u00fcr?<\/h3>\n<p><img decoding=\"async\" class=\"wp-image-5449 alignright\" src=\"https:\/\/docdrmuratkaya.com.tr\/wp-content\/uploads\/2025\/04\/yumusak-doku-tumoru-2-1.jpg\" alt=\"Yumu\u015fak Doku T\u00fcm\u00f6r\u00fc\" width=\"380\" height=\"199\" title=\"\" srcset=\"https:\/\/docdrmuratkaya.com.tr\/wp-content\/uploads\/2025\/04\/yumusak-doku-tumoru-2-1.jpg 1200w, https:\/\/docdrmuratkaya.com.tr\/wp-content\/uploads\/2025\/04\/yumusak-doku-tumoru-2-1-18x9.jpg 18w\" sizes=\"(max-width: 380px) 100vw, 380px\" \/><\/p>\n<p data-block-id=\"a96b3f4c-19ea-46c8-8d1e-49dafc5585de\">Bu t\u00fcm\u00f6rler, kas, ya\u011f, ba\u011f dokusu ve sinir gibi v\u00fccudun destekleyici dokular\u0131nda geli\u015fir. Her ya\u015f grubunda g\u00f6r\u00fclebilir, ancak genellikle yeti\u015fkinlerde daha s\u0131k rastlan\u0131r. Belirtiler \u00e7o\u011fu zaman yava\u015f ilerler. Hastalar fark etmeden kitle b\u00fcy\u00fcyebilir. Bu nedenle d\u00fczenli sa\u011fl\u0131k kontrolleri b\u00fcy\u00fck \u00f6nem ta\u015f\u0131r.<\/p>\n<p data-block-id=\"137d2a04-d894-4f7a-b13f-ffa7087d36fe\">Risk fakt\u00f6rleri aras\u0131nda genetik yatk\u0131nl\u0131k ve baz\u0131 \u00e7evresel etkiler bulunur. Ayr\u0131ca daha \u00f6nce uygulanm\u0131\u015f radyasyon tedavileri de riski art\u0131rabilir. Travma veya s\u00fcrekli zorlanma sonucu olu\u015fan b\u00f6lgelerde nadiren t\u00fcm\u00f6r geli\u015febilir. \u00c7o\u011fu iyi huyludur, ancak baz\u0131lar\u0131 h\u0131zl\u0131 b\u00fcy\u00fcyebilir ve \u00e7evre dokulara zarar verebilir.<\/p>\n<p data-block-id=\"6578083b-f18e-49f2-825a-24c4afd0c170\" data-pm-slice=\"1 1 []\">Te\u015fhis genellikle fizik muayene, g\u00f6r\u00fcnt\u00fcleme y\u00f6ntemleri ve biyopsi ile konur. Tedavi se\u00e7enekleri t\u00fcm\u00f6r\u00fcn t\u00fcr\u00fcne, boyutuna ve yerine ba\u011fl\u0131d\u0131r.<\/p>\n<p data-block-id=\"6578083b-f18e-49f2-825a-24c4afd0c170\" data-pm-slice=\"1 1 []\">Erken tan\u0131, tedavinin ba\u015far\u0131s\u0131n\u0131 art\u0131r\u0131r ve komplikasyon riskini azalt\u0131r. Bu nedenle h\u0131zl\u0131 b\u00fcy\u00fcyen veya a\u011fr\u0131l\u0131 kitlelerde <strong>yumu\u015fak doku t\u00fcm\u00f6r\u00fc<\/strong> olas\u0131l\u0131\u011f\u0131 dikkate al\u0131nmal\u0131d\u0131r. Ailelerin ve hastalar\u0131n fark\u0131ndal\u0131\u011f\u0131 erken te\u015fhis a\u00e7\u0131s\u0131ndan kritik \u00f6neme sahiptir. \u015e\u00fcpheli bir kitle fark edildi\u011finde vakit kaybetmeden doktora ba\u015fvurulmal\u0131d\u0131r. D\u00fczenli kontroller, ya\u015fam tarz\u0131 de\u011fi\u015fiklikleri ve doktorun \u00f6nerilerine uyum, tedavi s\u00fcrecinin etkinli\u011fini art\u0131r\u0131r.<\/p>\n<h3 data-block-id=\"b44c0206-b329-45e4-821e-944eabcfecd4\">Yumu\u015fak Doku T\u00fcm\u00f6r\u00fc Tedavi Y\u00f6ntemleri Nelerdir?<\/h3>\n<p data-block-id=\"a797d7f0-8b28-41ab-b781-f29580abc024\" data-pm-slice=\"1 1 []\">Cerrahi y\u00f6ntem, tedavide en s\u0131k tercih edilen y\u00f6ntemdir. T\u00fcm\u00f6r\u00fcn tamamen \u00e7\u0131kar\u0131lmas\u0131 ama\u00e7lan\u0131r. E\u011fer t\u00fcm\u00f6r s\u0131n\u0131rlar\u0131 belirginse ve \u00e7evre dokulara yay\u0131lmam\u0131\u015fsa, bu y\u00f6ntemle y\u00fcksek ba\u015far\u0131 elde edilir. Gerekirse etkilenen organ\u0131n bir k\u0131sm\u0131 ya da tamam\u0131 da al\u0131nabilir.<\/p>\n<p data-block-id=\"a797d7f0-8b28-41ab-b781-f29580abc024\" data-pm-slice=\"1 1 []\">Bu s\u00fcre\u00e7te <strong>yumu\u015fak doku t\u00fcm\u00f6r\u00fc<\/strong> varl\u0131\u011f\u0131 dikkate al\u0131n\u0131r ve cerrahi plan buna g\u00f6re \u015fekillendirilir. Radyoterapi, \u00f6zellikle cerrahiye ek olarak kullan\u0131l\u0131r. T\u00fcm\u00f6r\u00fcn yeniden b\u00fcy\u00fcmesini \u00f6nlemek ya da boyutunu k\u00fc\u00e7\u00fcltmek amac\u0131yla uygulanabilir. Ameliyat \u00f6ncesi radyoterapi, t\u00fcm\u00f6r\u00fc k\u00fc\u00e7\u00fclterek cerrahi i\u015flemi kolayla\u015ft\u0131rabilir.<\/p>\n<p data-block-id=\"60522b03-d611-4eef-8bbd-b9de5a337f4f\">Ameliyat sonras\u0131 radyoterapi ise geride kalan kanser h\u00fccrelerinin yok edilmesini sa\u011flar. Kemoterapi, \u00f6zellikle k\u00f6t\u00fc huylu (malign) t\u00fcm\u00f6rlerde tercih edilir. V\u00fccuda damar yoluyla ya da a\u011f\u0131zdan al\u0131nan ila\u00e7larla uygulan\u0131r. T\u00fcm\u00f6r\u00fcn yay\u0131l\u0131m\u0131n\u0131 durdurmay\u0131, k\u00fc\u00e7\u00fcltmeyi veya tamamen yok etmeyi ama\u00e7lar. Tek ba\u015f\u0131na veya cerrahi ile birlikte uygulanabilir. Ancak her t\u00fcm\u00f6r tipi kemoterapiye yan\u0131t vermez. Hedefe y\u00f6nelik tedavi y\u00f6nteminde, t\u00fcm\u00f6r h\u00fccrelerinin y\u00fczeyindeki \u00f6zel molek\u00fcller hedef al\u0131n\u0131r.<\/p>\n<p data-block-id=\"60522b03-d611-4eef-8bbd-b9de5a337f4f\">Normal dokulara zarar vermeden sadece t\u00fcm\u00f6r h\u00fccrelerini yok etmeyi ama\u00e7layan ila\u00e7lar kullan\u0131l\u0131r. Genellikle genetik analiz sonucu belirli mutasyonlar tespit edilen hastalarda uygulan\u0131r. Klasik kemoterapiye g\u00f6re daha az yan etkiye sahiptir. \u0130mm\u00fcnoterapi, ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin kanser h\u00fccrelerini tan\u0131y\u0131p yok etmesini sa\u011flayan ila\u00e7larla uygulan\u0131r. Bu y\u00f6ntem daha \u00e7ok ileri evre veya metastatik (yay\u0131lm\u0131\u015f) t\u00fcm\u00f6rlerde tercih edilir. T\u00fcm vakalarda etkili olmayabilir, bu y\u00fczden uygun hasta se\u00e7imi \u00f6nemlidir.<\/p>\n<p data-block-id=\"60522b03-d611-4eef-8bbd-b9de5a337f4f\">Bu t\u00fcr durumlarda cerrahiye veya tedaviye gerek kalmadan d\u00fczenli g\u00f6r\u00fcnt\u00fcleme ve muayene ile sadece izlenir. T\u00fcm\u00f6r b\u00fcy\u00fcrse veya rahats\u0131zl\u0131k verirse m\u00fcdahale edilir. Tedavi sonras\u0131 kas g\u00fcc\u00fc, hareket kabiliyeti veya ya\u015fam kalitesinde azalma olabilir. Bu nedenle fizik tedavi, psikolojik destek, beslenme dan\u0131\u015fmanl\u0131\u011f\u0131 gibi ek tedaviler uygulan\u0131r. Hastan\u0131n tedaviye uyum sa\u011flamas\u0131 ve ya\u015fam kalitesini s\u00fcrd\u00fcrebilmesi a\u00e7\u0131s\u0131ndan \u00f6nemlidir.<\/p>","protected":false},"excerpt":{"rendered":"<p>Kas, ya\u011f, sinir, damar gibi dokularda olu\u015fan anormal h\u00fccre b\u00fcy\u00fcmesidir. Yumu\u015fak doku t\u00fcm\u00f6r\u00fc, genellikle iyi huyludur. Bazen k\u00f6t\u00fc huylu olabilir. V\u00fccudun her yerinde g\u00f6r\u00fclebilir. \u015ei\u015flik, a\u011fr\u0131 ya da hareket k\u0131s\u0131tl\u0131l\u0131\u011f\u0131 yapabilir. Tan\u0131 i\u00e7in g\u00f6r\u00fcnt\u00fcleme ve biyopsi gerekir. Erken te\u015fhis \u00f6nemlidir. Tedavi genellikle cerrahi ile yap\u0131l\u0131r. Gerekirse ek tedaviler uygulan\u0131r. Yumu\u015fak Doku T\u00fcm\u00f6r\u00fc Belirtileri Nelerdir? V\u00fccutta [&hellip;]<\/p>","protected":false},"author":1,"featured_media":5450,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4562","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-genel"],"_links":{"self":[{"href":"https:\/\/docdrmuratkaya.com.tr\/en\/wp-json\/wp\/v2\/posts\/4562","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/docdrmuratkaya.com.tr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/docdrmuratkaya.com.tr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/docdrmuratkaya.com.tr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/docdrmuratkaya.com.tr\/en\/wp-json\/wp\/v2\/comments?post=4562"}],"version-history":[{"count":5,"href":"https:\/\/docdrmuratkaya.com.tr\/en\/wp-json\/wp\/v2\/posts\/4562\/revisions"}],"predecessor-version":[{"id":5451,"href":"https:\/\/docdrmuratkaya.com.tr\/en\/wp-json\/wp\/v2\/posts\/4562\/revisions\/5451"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/docdrmuratkaya.com.tr\/en\/wp-json\/wp\/v2\/media\/5450"}],"wp:attachment":[{"href":"https:\/\/docdrmuratkaya.com.tr\/en\/wp-json\/wp\/v2\/media?parent=4562"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/docdrmuratkaya.com.tr\/en\/wp-json\/wp\/v2\/categories?post=4562"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/docdrmuratkaya.com.tr\/en\/wp-json\/wp\/v2\/tags?post=4562"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}